These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 2765673
1. Change of deformability and Heinz body formation in G6PD-deficient erythrocytes treated with 5-hydroxy-6-desmethylprimaquine. Thompson SF, Fraser IM, Strother A, Bull BS. Blood Cells; 1989; 15(2):443-52; discussion 453-4. PubMed ID: 2765673 [Abstract] [Full Text] [Related]
2. Erythrocyte membrane ATPase activity of G6PD-deficient individuals and the effect of primaquine metabolite(s) on membrane ATPase enzymes. Akoğlu T, Ozdoğu H, Erdoğan R, Ozer FL. J Trop Med Hyg; 1984 Oct; 87(5):219-24. PubMed ID: 6152296 [Abstract] [Full Text] [Related]
3. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients]. Grieger M, Schippel W, Siems W, Leppin K. Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Oct; 110(5):704-15. PubMed ID: 6198254 [Abstract] [Full Text] [Related]
4. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Toxicology; 2012 Mar 29; 294(1):54-60. PubMed ID: 22330256 [Abstract] [Full Text] [Related]
5. Enhanced susceptibility of erythrocytes deficient in glucose-6-phosphate dehydrogenase to alloxan/glutathione-induced decrease in red cell deformability. Liu TZ, Lin TF, Hung IJ, Wei JS, Chiu DT. Life Sci; 1994 Mar 29; 55(3):PL55-60. PubMed ID: 8007756 [Abstract] [Full Text] [Related]
6. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. Fletcher KA, Barton PF, Kelly JA. Biochem Pharmacol; 1988 Jul 01; 37(13):2683-90. PubMed ID: 2839199 [Abstract] [Full Text] [Related]
7. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia. Wang YM, Patterson JH, Van Eys J. J Clin Invest; 1971 Jul 01; 50(7):1421-8. PubMed ID: 4397414 [Abstract] [Full Text] [Related]
8. Changes in red blood cell membrane structure in G6PD deficiency: an atomic force microscopy study. Tang J, Jiang C, Xiao X, Fang Z, Li L, Han L, Mei A, Feng Y, Guo Y, Li H, Jiang W. Clin Chim Acta; 2015 Apr 15; 444():264-70. PubMed ID: 25748035 [Abstract] [Full Text] [Related]
9. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine. Bowman ZS, Oatis JE, Whelan JL, Jollow DJ, McMillan DC. J Pharmacol Exp Ther; 2004 Apr 15; 309(1):79-85. PubMed ID: 14724225 [Abstract] [Full Text] [Related]
10. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals. Gurbuz N, Yalcin O, Aksu TA, Baskurt OK. Clin Hemorheol Microcirc; 2004 Apr 15; 31(3):235-42. PubMed ID: 15322329 [Abstract] [Full Text] [Related]
11. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. Fraser IM, Vesell ES. J Pharmacol Exp Ther; 1968 Jul 15; 162(1):155-65. PubMed ID: 5656594 [No Abstract] [Full Text] [Related]
17. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency. Ali NA, al-Naama LM, Khalid LO. East Mediterr Health J; 1999 May 15; 5(3):457-64. PubMed ID: 10793824 [Abstract] [Full Text] [Related]